As expected, the mRNA expression levels of ACLY, ACACA, FASN and ELOVL5 were observably lower compared to the control group with the silencing of EN2 in GBM cells (Figures 5E and S2D). The gene discussed is ELOVL5; the disease is glioblastoma.